Clinical Trials Logo

Clinical Trial Summary

This study, a Randomized controlled trial of Autologous microbiome reconstitution to prevent Colonization by antibiotic rEsistant bacteria (RACE), seeks to investigate the safety, feasibility and the role of autologous fecal microbiota transplantation (FMT) for the prevention of antibiotic resistant bacteria (ARB) through microbiome restoration.


Clinical Trial Description

Note: The Protocol and Statistical Analysis Plan document contains modifications from what is on file at the FDA to reflect redactions and formatting requirements for public posting on ClinicalTrials.gov ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03061097
Study type Interventional
Source Microbiome Health Research Institute
Contact
Status Completed
Phase Phase 1
Start date July 10, 2017
Completion date June 18, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06262009 - Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment
Completed NCT04212403 - Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) N/A
Recruiting NCT04460313 - Nasopharyngeal Carriage of S. Pneumoniae N/A
Active, not recruiting NCT03208725 - Childhood Acute Illness and Nutrition Network
Completed NCT03963297 - Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
Active, not recruiting NCT05027893 - Complications After Lower Third Molar Surgery N/A
Completed NCT05551988 - Predictors of Foot Amputation in Diabetic Foot Ulcers
Not yet recruiting NCT04795518 - The Pattern of Antibiotic Prescription for Children Among a Group of Pediatric Dentists.
Recruiting NCT03767283 - Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
Withdrawn NCT03391674 - Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization N/A
Recruiting NCT04107194 - Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. Phase 3
Completed NCT03884348 - Tailored H. Pylori Eradication Based on Clarithromycin Resistance
Completed NCT04926935 - Bloodstram Infections in ICU. Single Centre Observational Study.
Not yet recruiting NCT04269174 - The Utility of Biofire Filmarray in Evaluation of Entero Pathogens Triggers in Patients With Chronic Diarrhea
Completed NCT03167398 - Fecal Microbiota Transplantation for Eradication of CRE Phase 1/Phase 2
Completed NCT03866291 - ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
Completed NCT01902589 - Resistance of Helicobacter Pylori to Antibiotics in Children N/A
Not yet recruiting NCT04593368 - Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) Phase 2
Completed NCT03063437 - A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization Phase 2
Active, not recruiting NCT03140410 - Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis N/A